Trenbolone Enanthate
Tren E
Half-life
5 days
Time to Peak
3 days
Steady State
~25 days
Bioavailability
100%
Dose Range
100–400 mg
Frequency
2x weekly
Overview
Long-acting trenbolone ester. No pharmaceutical product has ever existed — exclusively UGL. PK estimates are entirely based on ester analogy (enanthate ester behaves similarly regardless of parent compound) and community experience. Allows less frequent dosing than acetate (2x/week vs daily/EOD). Same potency and side effect profile as trenbolone acetate but slower onset and slower clearance. Harm reduction: Same risks as trenbolone acetate. The longer ester means side effects take longer to clear if the compound is discontinued — acetate may be preferred for first-time users who want faster clearance if problems arise. Monitor: Lipids, liver, kidney, hematocrit, blood pressure, mental health.
Mechanism of Action
19-nor steroid with 9,11-double bond. Enanthate ester for extended depot release. Same parent compound as trenbolone acetate.
Dosing Information
| Route | Dose Range | Half-life | Tmax | Frequency |
|---|---|---|---|---|
| Intramuscular (IM) | 100–400 mg | 5 days | 3 days | 2x weekly, Weekly |
Storage & Handling
Room temperature — Oil-based injectable (UGL only).
Used in Regimens
Trenbolone Enanthate is not currently part of any catalog regimen.
Data Sources
- ester analogy Enanthate ester analogy — based on testosterone enanthate release kinetics
Related Tools
Track Trenbolone Enanthate with Doseline
Reminders, medication level charts, injection site rotation, and protocol tracking — all free, all private.
Join the waitlistDoseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.